Her3 as a determinant for the prognosis of melanoma

Details Her3 as a determinant for the prognosis of melanoma Her3 as a determinant for the prognosis of melanoma

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 35/04 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01) C12N 15/113 (2010.01) A61K 31/7088 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2714940

The present invention relates to an inhibitor of HER3 for the treatment of melanoma, in particular melanoma metastases and/or refractory melanoma, pharmaceutical compositions comprising such an inhibitor and a method for the diagnosis or prognosis of melanoma.

La présente invention concerne un inhibiteur de HER3 pour le traitement du mélanome, en particulier des métastases de mélanome et/ou un mélanome réfractaire, des compositions pharmaceutiques comprenant un tel inhibiteur et un procédé pour le diagnostic ou le pronostic du mélanome.

Affiliated with

Also associated with

Rating

Her3 as a determinant for the prognosis of melanoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Her3 as a determinant for the prognosis of melanoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Her3 as a determinant for the prognosis of melanoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1380223